Drug Type Small molecule drug, Hormone |
Synonyms |
Target |
Mechanism INSR agonists(Insulin receptor agonists), glucokinase activators(Glucokinase activators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC22H27ClN4O5 |
InChIKeyHMUMWSORCUWQJO-QAPCUYQASA-N |
CAS Registry1191995-00-2 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Preclinical | CN | 28 Sep 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | CN | 28 Sep 2023 |